Biopharmaceutical manufacturer.
21st Century Cures draft legislation, specifically those sections relating to regulatory and reimbursement policies affecting the biotechnology industry.
Policy issues relating to orphan drugs, dormant therapies and medicines for rare diseases.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 2, the "Medicare Access and CHIP Reauthorization Act.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program. 
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," including policy and implementation issues.
Public Law No. 110-85, the "Food and Drug Administration Amendments Act," including current policy issues relating to FDA's Risk Evaluation and Mitigation Strategy authority.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS